Skip to content
- Novel mutations in BRCA2 intron 11 and overexpression of COX-2 and BIRC3 mediate cellular resistance to PARP inhibitors.
- Chen HD, Guo N, Song SS, Chen CH, Miao ZH, He JX.
- Am J Cancer Res. 2020 Sep 1;10(9):2813-2831.
- Somatic mutation profiling in BRCA-negative breast and ovarian cancer patients by multigene panel sequencing.
- Kwong A, Cheuk IW, Shin VY, Ho CY, Au CH, Ho DN, Wong EY, Yu SW, Chen J, Chan KK, Ngan HY, Chan TL, Ma ES.
- Am J Cancer Res. 2020 Sep 1;10(9):2919-2932.